Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-135-0 | CAS number: 10043-01-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Epidemiological studies of aluminum exposure via drinking water
Overall, many of the studies of aluminium in drinking water and risk of cognitive impairment, dementia and/or AD have had methodological weaknesses. Early studies were ecological, taking into account only the level of cognitive impairment, dementia, or AD in relation to aluminium in drinking water. Most of the case-control and cohort studies took few or no possible confounders or effect modifiers into account in their analyses. The exception to this is the analysis by Rondeau et al. (2000), which is by far the strongest methodologically of the epidemiological studies conducted to date. However, one limitation of this study is a lack of an intermediate exposure category, and therefore the inability to examine the possibility of a dose-response relationship.
Epidemiological investigations of exposure to aluminum in antacids and antiperspirants
Only very weak or no associations have been found between repeated exposures to aluminum in antacids and AD in a number of analytical epidemiological studies ( Graves et al. 1990; Flaten et al. 1991; Lindsay et al. 2002). Positive associations between AD and the use of aluminum containing antiperspirants were reported in two case-control studies, but the interpretation of the results is difficult due to methodological limitations of the studies (e.g., missing data, and misclassification due to varying brands and subtypes of antiperspirant with varying aluminum contents) (Graves et al. 1990;). This positive observation, however, was not supported by a follow-up study on the CSHA21 cohort (Lindsay et al. 2002); the results show that regular use of antiperspirant did not increase the risk of AD.
Aluminium in food
Although the main source of exposure to aluminium for most people probably is food, it is believed that very little is absorbed. There have only been a few epidemiological studies of the effects of aluminium in food in the general population.
Additional information
-
Martyn CN, Barker DJ, Osmond C, Harris EC, Edwardson JA, Lacey RF, Geographical relation between Alzheimer's disease and aluminum in drinking water, Lancet 1989 Jan 14;1(8629):59-62.
-
Flaten TP. Geographical associations between aluminium in drinking water and death rates with dementia (including Alzheimer’s disease), Parkinson’s disease and amyotrophic lateral sclerosis in Norway. Environ Geochem Health. 1990;12:152–167.
-
Frecker MF. Dementia in Newfoundland: Identification of a geographical isolate? J Epidemiol Comm Health. 1991;45:307–311.
-
Neri LC, Hewitt D, Aluminium, Alzheimer's disease, and drinking water, Lancet 1991 Aug 10;338(8763):390
- Forbes WF, Hayward LM, Agwani N,Dementia, aluminium, and fluoride,Lancet 1991 Dec 21-28;338(8782-8783):1592-3.
-
Wettstein A, Aeppli J, Gautschi K, Peters M, Failure to find a relationship between mnestic skills of octogenarians and aluminum in drinking water. Int Arch Occup Environ Health, 1991;63(2):97-103.
-
Jacqmin H, Commenges D, Letenneur L, Barberger-Gateau P, Dartigues JF.,Components of drinking water and risk of cognitive impairment in the elderly,Am J Epidemiol1994 Jan 1;139(1):48-57
-
Jacqmin-Gadda H, Commenges D, Letenneur L, Dartigues JF,Silica and aluminum in drinking water and cognitive impairment in the elderly,Epidemiology. 1996 May;7(3):281-5.
-
Forster DP, Newens AJ, Kay DW, Edwardson JA. Risk factors in clinically diagnosed presenile dementia of the Alzheimer type: a case-control study in northern England. J Epidemiol Commun Health. 1995;49:253–258.
-
Taylor GA, Newens AJ, Edwardson JA, Kay DW, Forster DP.,Alzheimer's disease and the relationship between silicon and aluminium in water supplies in northern England.,J Epidemiol Community Healt.1995 Jun;49(3):323-4
-
McLachlan DR, Bergeron C, Smith JE, Boomer D, Rifat SL,Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories,Neurology.1996 Feb;46(2):401-5.
-
Sohn SJ, Shin JH, Park YS, Rhee JA, Choi JS. Components of drinking water and risk of cognitive impairment in the rural elderly. Chonnam J Med Sci. 1996;9:189–193
-
Martyn CN, Coggon DN, Inskip H, Lacey RF, Young WF,Aluminum concentrations in drinking water and risk of Alzheimer's disease,Epidemiology 1997 May;8(3):281-6
-
Gauthier E, Fortier I, Courchesne F, Pepin P, Mortimer J, Gauvreau D. Aluminium forms in drinking water and risk of Alzheimer’s disease. Environ Res A. 2000;84:234–246
-
Rondeau V, Commenges D, Jacqmin-Gadda H, Dartigues JF.,Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study.,Am J Epidemiol. 2000 Jul 1;152(1):59-66.
- Rogers MA, Simon DG. A preliminary study of dietary aluminum intake and risk of Alzheimer’s disease. Age Aging. 1999;28:205–209.
A number of studies have examined the effects of aluminium in drinking water on cognitive impairment and dementia including AD, as well as other neurological conditions such as Parkinson=s disease and amyotrophic lateral sclerosis. These studies are listed in
Table 1.
Table 1
Summary of epidemiological studies of aluminium in drinking water and cognitive impairment, dementia and AD.
Study |
Design |
Subjects |
Age range |
Outcome measures |
Case ascertainment |
Association with aluminium |
Martyn et al. (1989), UK |
Ecological study |
445 probable AD, 221 possible AD, 519 other dementia |
40-69 years |
Probable AD, possible AD, other dementia |
Computerized tomographic scanning |
Positive for probable AD (statistically significant) |
Flaten (1990), Norway |
Ecological study |
14,727 subjects, 586 demented |
|
Dementia |
Death certificates |
Positive (statistically significant) |
Frecker (1991), Canada |
Ecological study |
568,345 total deaths, 379 demented |
|
Dementia |
Death certificates |
Positive (statistically significant) |
Neri & Hewitt (1991), Canada |
Ecological study, case-control analysis |
2,232 AD or presenile dementia, 2,232 controls |
55 years and over |
AD, presenile dementia |
Hospitalization records |
Positive (statistically significant) |
Forbes et al. (1991;1992;1994), Canada |
Prospective cohort |
782 subjects, 400 with some symptoms of mental impairment |
45 years at baseline |
Impaired mental functioning |
Questionnaire completed by the subjects and verified by family members |
Positive if aluminium high and fluoride low or high (statistically significant) |
Wettstein et al. (1991), Switzerland |
Population survey |
805 subjects, 99 demented |
82-85 years |
Mnestic and naming skills |
Mnestic and naming subtests of the MMSE. |
No statistically significant association |
Jacqmin et al. (1994),Jacqmin- Gadda et al. (1996), France |
Prospective cohort |
3,777 subjects |
65 years and over |
Cognitive impairment |
Score <24 on Mini- Mental State Exam |
Positive for aluminium only if silica and pH low (statistically significant) |
Forster et al. (1995),Taylor et al. (1995), UK |
Case-control |
109 PDAT, 109 controls |
<65 years |
Presenile dementia of the Alzheimer type |
Clinical diagnosis |
No statistically significant association |
McLachlan et al. (1996), Canada |
Case-control |
119 AD, 51 controls |
|
AD |
Autopsy |
Positive (statistically significant) |
Sohn et al. (1996), Korea |
Cross-sectional study |
558 subjects, 45 cognitively impaired |
60 years and over |
Cognitive impairment |
Mini Mental State test, Korean version |
No statistically significant association |
Martyn et al. (1997), UK |
Case-control |
Males only; 106 AD, 441 controls |
Born from 1916 to 1945 |
AD |
Computerized tomographic (CT) records, review of hospital case notes |
No statistically significant association |
Gauthier et al. (2000), Canada |
Case-control |
68 AD, 68 controls |
70 years and over |
AD |
Clinical diagnosis |
Positive (statistically significant) association with organic monomeric Al.; negative for all forms of Al. |
Rondeau et al. (2000), France |
Prospective cohort |
253 demented, 182 AD |
65 years and over |
AD and dementia |
Clinical diagnosis |
Positive (statistically significant) |
References:
Aluminium in antacids and antiperspirants
Graves et al. (1990) conducted a case-control study to investigate the association between exposure to aluminium, from the lifetime use of antiperspirants and antacids, and the risk of AD. Subjects diagnosed with AD were selected from one of two clinics. Selection of cases was limited to those who were married at the time of diagnosis since the spouse served as an informant. Friends of the case and/or informant were selected as controls; when this was not possible, a non-blood relative of the case was identified. The controls were within 10 years of age of the cases and did not suffer from memory loss. Case and control informants were interviewed about the subjects’ antiperspirant/deodorant use and antacid use. Subjects were defined as an antiperspirant/deodorant user if they were reported to have used these products at least once a month for one year prior to the reference year. Frequency, duration, and the name of the most common brands used were also obtained. A subject was considered to have been exposed to antacids if he or she had used antacids daily or almost daily for at least one year prior to the reference year. One hundred and thirty case-control pairs were included in this analysis. The age-adjusted OR for use of aluminium-containing antiperspirants vs. no use of antiperspirant was 1.7 (95% CI: 1.1-2.4). This component of the analysis included only 63 matched pairs as a result of missing information. There was a statistically significant dose-response relationship between the lifetime use of aluminium-containing antiperspirants and the risk of AD, adjusted for age (p = 0.01). The age-adjusted OR for antacid use vs. no use was 3.1 (95% CI: 1.3-7.5). A dose-response gradient was found for any antacid use (p = 0.009), and the adjusted OR for the highest level of exposure was 11.66 (95% CI: 1.28-106.4). However, no association was found when only aluminium-containing antacids were considered (OR=0.8, 95% CI: 0.3-2.1). There are some methodological issues which should be considered in interpreting the results of this study. The necessary use of surrogate informants may have resulted in misclassification of exposure data and a high frequency of missing information. Also the small numbers of subjects in the exposure categories, especially in the subanalyses, may have led to unstable estimates of the ORs.
Flaten et al. (1991) compared the rate of mortality from dementia (as an underlying or contributory cause) of a cohort of 4,179 patients who had surgery for gastro-duodenal ulcer disease between 1911 and 1987 to national rates. It was assumed that the majority of the patients operated on after 1963 were heavy users ofantacids containing aluminium, although no precise exposure information was available. No statistically significant results were seen. The SMR for dementia was 1.10 (95% CI: 0.85 – 1.40, n=64) for all patients, and for those operated on in the period 1967-78 it was 1.25 (95% CI: 0.66 – 2.13, n=13). Limitations of the study include misclassification both in diagnosis and exposure; in addition, the observation period may have been too short to detect an effect. Thus the possibility of an effect cannot be ruled out based on this study.
The Canadian Study of Health and Aging included a prospective analysis of risk factors for AD (Lindsay et al., 2002). The baseline population of this study was comprised of 6,434 subjects aged 65 years or older in 1991. Of these, 4,615 subjects participated in the follow-up study in 1996. The analysis included 194 AD cases, and 3,894 cognitively normal controls. Detailed information regarding a variety of risk factors was obtained through a self-administered questionnaire completed by the subjects at baseline. No association was found between the regular use ofantiperspirants OR=0.77 (95% CI: 0.55-1.08), or antacid use OR=0.91 (95% CI: 0.65-1.26) and the risk of AD.
Aluminium in food
Although the main source of exposure to aluminium for most people probably is food, it is believed that very little is absorbed (Marcus et al., 1992). There have only been a few epidemiological studies of the effects of aluminium in food in the general population. A small study (23 cases, 23 matched controls) reported positive results (Rogers & Simon, 1999). While they reported on some aspects of medical history, there is no indication that they considered possible differences between cases and controls in renal function or vitamin deficiencies relevant to cognitive decline. A comprehensive review of the role of diet in cognitive decline (Solfrizzi et al., 2003) referred to the possibility of a link between aluminium in the diet and AD as “controversial”.Rogers and Simon (1999) conducted a pilot study to examine dietary differences in individuals with AD and matched controls (n = 46: 23 subjects, 23 controls). The exposure assessment was based on questionnaires to determine past dietary habits. According to the authors, there may be an association between AD and the consumption of foods containing high levels of aluminum food additives. However, the sample size was very small and the association was statistically significant only for one category of food (pancake, waffle and biscuit).
References:
Aluminium in vaccines
Verreault et al. (2001) examined the association between past exposure to conventional vaccines and the risk of AD in order to determine if changes to the immune system could be a factor in the development of this condition. The study population in this investigation consisted of subjects 65 years of age or older who participated in the Canadian Study of Health and Aging, which is a prospective cohort study of dementia. Subjects were screened for dementia at baseline, and cognitively normal subjects completed a risk factor questionnaire which included information about exposure to vaccines. Respondents were asked whether they had ever received vaccinations for tetanus, diphtheria, poliomyelitis, or influeneza. Subjects were screened again for dementia 5 years later. Multivariate logistic regression models were used to determine the association between vaccine exposure and the risk of AD, and to adjust for a variety of other suspected risk factors. One hundred and eighty three subjects, with information about past exposure to vaccines, were diagnosed with probable or possible AD during the 5 year follow up period; 3,682 subjects remained cognitively normal at follow-up. A statistically significant lower risk of AD was demonstrated for subjects who reported at least one vaccination against diptheria/tetanus (OR=0.40, 95% CI: 0.25-0.65), and at least one vaccination against poliomyelitis (OR=0.54, 95% CI: 0.30-0.97). Exposure to influenza vaccine was also associated with a lower risk of AD but did not reach statistical significance (OR= 0.81, 95% CI: 0.55-1.19). These results suggest that past exposure to vaccines may protect against the development of AD.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)